Life Science REIT PLC Result of AGM (7151A)
25 Mai 2023 - 5:15PM
UK Regulatory
TIDMLABS
RNS Number : 7151A
Life Science REIT PLC
25 May 2023
Life Science REIT plc
(the "Company")
LEI: 213800RG7JNX7K8F7525
25 May 2023
Annual General Meeting ("AGM") Results
The Company announces that at its Annual General Meeting held
earlier today all the resolutions set out in the Notice of Annual
General Meeting were passed. All resolutions were voted on by way
of a poll. The results of the poll for each resolution were as
follows:
For Against
No. of No. of shares % Votes Withheld
shares % (No. of
Resolution shares)
1. To receive and approve
the annual report and financial
statements 237,307,165 100.00% 10,345 0.00% 19,548
2. To receive and approve
the Directors' remuneration
report 236,497,636 99.68% 761,688 0.32% 77,734
3. To re-elect Claire Boyle
as a Director of the Company 227,063,288 95.69% 10,227,912 4.31% 45,858
4. To re-elect Sally Ann Forsyth
as a Director of the Company 197,662,892 90.55% 20,630,888 9.45% 19,043,278
5. To re-elect Michael Taylor
as a Director of the Company 236,321,834 99.59% 969,366 0.41% 45,858
6. To re-elect Richard Howell
as a Director of the Company 236,350,144 99.59% 969,366 0.41% 17,548
7. To appoint Deloitte LLP
as Auditor to the Company 237,257,249 99.97% 63,261 0.03% 16,548
8. To authorise the Audit
and Risk Committee to determine
the remuneration of the Auditor
to the Company 237,267,855 99.99% 24,345 0.01% 44,858
9. To approve the Company's
dividend payment policy 237,287,855 100.00% 10,345 0.00% 38,858
10. To authorise the Directors
to allot equity securities 228,003,637 96.08% 9,294,563 3.92% 38,858
11. To authorise the Directors
to disapply pre-emption rights* 226,872,038 95.61% 10,420,162 4.39% 44,858
12. To authorise the Directors
to disapply pre-emption rights
for the purposes of financing
an acquisition or other capital
investment* 225,728,875 95.13% 11,563,325 4.87% 44,858
13. To approve the purchase
of the Company's own shares* 227,477,570 95.87% 9,800,639 4.13% 58,849
14. That a general meeting,
other than an AGM, may be
called on not less than 14
clear days' notice* 236,894,091 99.83% 404,109 0.17% 38,858
*special resolution
NOTES:
1. All resolutions were passed.
2. Percentages have been rounded to two decimal places.
3. Proxy appointments which gave discretion to the Chair
of the AGM have been included in the "For" total for
the appropriate resolution.
4. Votes "For" and "Against" any resolution are expressed
as a percentage of votes validly cast for that resolution.
5. A "Vote withheld" is not a vote in law and is not counted
in the calculation of the percentage of shares voted
"For" or "Against" any resolution.
6. The number of shares in issue at 6:00 pm. on 23 May
2023 was 350,000,000 ordinary shares, carrying one
vote each, and at that time, the Company did not hold
any shares in treasury.
7. The full text of the resolutions passed at the AGM
can be found in the Notice of Annual General Meeting
which is available on the Company's website at
https://lifesciencereit.co.uk/investors/shareholder-information/
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
RAGAAMATMTBTBJJ
(END) Dow Jones Newswires
May 25, 2023 11:15 ET (15:15 GMT)
Life Science Reit (LSE:LABS)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Life Science Reit (LSE:LABS)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024